Lactoferrin enhances peripheral opioid-mediated antinociception via nitric oxide in rats

European Journal of Pharmacology

Volumn 484, Issue 2-3, 2004, Pages 175-181

  Hayashida, Ken Ichiro ^a   Takeuchi, Takashi ^a   Harada, Etsumori ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

D Phe Cys Tyr D Trp Orn Thr NH2; Formalin test; Lactoferrin; NG nitro L arginine methyl ester

Indexed keywords

ANTINOCICEPTIVE AGENT; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; FORMALDEHYDE; LACTOFERRIN; MORPHINE; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENANTIOMER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 1642546479     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.11.007     Document Type: Article

References (32)

1. Anderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:2001;593-615.
2. Brock J.H. The physiology of lactoferrin. Biochem. Cell. Biol. 80:2002;1-6.
3. Cabot P.J. Immune-derived opioids and peripheral antinociception. Clin. Exp. Pharmacol. Physiol. 28:2001;230-232.
4. Caccavo D., Sebastiani G.D., Di Monaco C., Guido F., Galeazzi M., Ferri G.M., Bonomo L., Afeltra A. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis. Int. J. Clin. Lab. Res. 29:1999;30-35.
5. Durate I.D., Lorenzetti B.B., Ferreira S.H. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J.Pharmacol. 186:1990;289-293.
6. Faucheux B.A., Nillesse N., Damier P., Spik G., Mouatt-Prigent A., Pierce A., Leveugle B., Kubis N., Hauw J.J., Agid Y. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9603-9607.
7. Ferreira S.H., Nakamura M. -Prostaglandin hyperalgesia: relevance of the peripheral effect for the analgesic action of opioid-antagonist. Prostaglandins. 18:1979;201-208.
8. Ferreira S.H., Duarte I.D., Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur. J. Pharmacol. 201:1991;121-122.
9. Granados-Soto V., Rufino M.O., Gomes Lopes L.D., Ferreira S.H. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol. 340:1997;177-180.
10. Hayashida K., Takeuchi T., Shimizu H., Ando K., Harada E. Novel function of bovine milk-derived lactoferrin on antinociception mediated by mu-opioid receptor in the rat spinal cord. Brain Res. 965:2003;239-245.
11. Hayashida K., Takeuchi T., Shimizu H., Ando K., Harada E. Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord. Am. J. Physiol., Regul. Integr. Comp. Physiol. 285:2003;R306-R312.
12. Kawabata A., Manabe S., Manabe Y., Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol. 112:1994;547-550.
13. Kolesnikov Y.A., Pan Y.X., Babey A.M., Jain S., Wilson R., Pasternak G.W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. U. S. A. 94:1997;8220-8225.
14. Levay P.F., Viljoen M. Lactoferrin: a general review. Haematologica. 80:1995;252-267.
15. Leveugle B., Faucheux B.A., Bouras C., Nillesse N., Spik G., Hirsch E.C., Agid Y., Hof P.R. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol. (Berl). 91:1996;566-572.
16. Levine J.D., Taiwo Y.O. Involvement of mu-opiate receptor in peripheral analgesia. Neuroscience. 32:1989;571-575.
17. Maffei F.A., Heine R.P., Whalen M.J., Mortimer L.F., Carcillo J.A. Levels of antimicrobial molecules defensin and lactoferrin are elevated in the cerebrospinal fluid of children with meningitis. Pediatrics. 103:1999;987-992.
18. Malmberg A.B., Yaksh T.L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 263:1992;136-146.
19. Masson P.L., Heremans J.F. Lactoferrin in milk from different species. Comp. Biochem. Physiol., B. 39:1971;119-129.
20. Masson P.L., Heremans J.F., Dive C. An iron-binding protein common to many external secretions. Clin. Chim. Acta. 14:1966;735-739.
21. Nozaki-Taguchi N., Yamamoto T. The interaction of FK409, a novel nitric oxide releaser, and peripherally administered morphine during experimental inflammation. Anesth. Analg. 86:1998;367-373.
22. Qian Z.M., Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res. Brain Res. Rev. 27:1998;257-267.
23. Smith T.W., Buchan P. Peripheral opioid receptors located on the rat saphenous nerve. Neuropeptides. 5:1984;217-220.
24. Sorimachi K., Akimoto K., Hattori Y., Ieiri T., Niwa A. Activation of macrophages by lactoferrin: secretion of TNF-alpha, IL-8 and NO. Biochem. Mol. Biol. Int. 43:1997;79-87.
25. Stefano G.B., Goumon Y., Casares F., Cadet P., Fricchione G.L., Rialas C., Peter D., Sonetti D., Guarna M., Welters I.D., Bianchi E. Endogenous morphine. Trends Neurosci. 23:2000;436-442.
26. Stein C., Machelska H., Binder W., Schafer M. Peripheral opioid analgesia. Curr. Opin. Pharmacol. 1:2001;62-65.
27. Suzuki Y.A., Lonnerdal B. Characterization of mammalian receptors for lactoferrin. Biochem. Cell Biol. 80:2002;75-80.
28. Takeuchi T., Hayashida K., Inagaki H., Kuwahara M., Tsubone H., Harada E. Opioid mediated suppressive effect of milk-derived lactoferrin on distress induced by maternal separation in rat pups. Brain Res. 979:2003;216-224.
29. Teng C.T. Lactoferrin gene expression and regulation: an overview. Biochem. Cell. Biol. 80:2002;7-16.
30. Teschemacher H. Lactoferrin elicits opioid-mediated antinociception without development of tolerance: central nNOS-1 set off duty? Am. J. Physiol., Regul. Integr. Comp. Physiol. 285:2003;R302-R305.
31. Teschemacher H., Koch G. Opioids in the milk. Endocr. Regul. 25:1991;147-150.
32. Wheeler-Aceto H., Porreca F., Cowan A. The rat paw formalin test: comparison of noxious agents. Pain. 40:1990;229-238.